Clinical Trials Logo

BK Virus clinical trials

View clinical trials related to BK Virus.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02659891 Completed - Clinical trials for Kidney Transplantation

IVIg to Treat BK Viremia in Kidney Transplant Recipients

Start date: May 2016
Phase: Phase 1
Study type: Interventional

The overall goal of this study is to rapidly improve clearance of BK viremia with Immunoglobulin (Privigen®) thereby decreasing the potential for formation of alloantibodies in renal transplant recipients that have had immunosuppression reduction due to BK viremia. Our approach is to perform a prospective, randomized, placebo controlled trial intravenous immune globulin (IVIg; Privigen®) plus protocolized immunosuppression reduction versus placebo and protocolized immunosuppression reduction in patients with BK viremia post-kidney transplantation.